On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy.
Pablo NenclaresLucinda GunnHeba SolimanMateo BoverAmy TrinhIsla LeslieKee Howe WongAlan MelcherKate NewboldChris M NuttingDerfel Ap DafyddShreerang A BhideKevin J HarringtonPublished in: Journal for immunotherapy of cancer (2022)
NLR and fibrinogen levels are simple, inexpensive and readily available biomarkers that could be incorporated into an on-treatment scoring system and used to help predict survival and response to ICI in patients with R/M HNSCC.